Ignite Creation Date:
2024-05-06 @ 8:53 AM
Last Modification Date:
2024-10-26 @ 12:06 PM
Study NCT ID:
NCT02841852
Status:
COMPLETED
Last Update Posted:
2016-07-26
First Post:
2016-07-20
Brief Title:
Inappropriate Prescribing of Proton-pump Inhibitor is it Associated With the Burden of Comorbidities in Older Patients
Sponsor:
Nantes University Hospital
Organization:
Nantes University Hospital
Study Overview
Official Title:
Inappropriate Prescribing of Proton-pump Inhibitor is it Associated With the Burden of Comorbidities in Older Patients Over 75 Years Old
Status:
COMPLETED
Status Verified Date:
2016-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
IPP SA
Brief Summary:
Proton pump inhibitors PPIs are one of the most frequently prescribed classes of drugs in the world and the most effective drugs available to reduce gastric acid secretion However studies have shown that PPIs are not always prescribed with a clear indication Indeed between 25 and 86 of older individuals taking a PPI have been overprescribed these medications In older patients overprescribing of a PPI is associated with increases in morbidity adverse drug events hospitalization and mortality The hypothesis is that overprescription of PPIs is associated with the individual multimorbidities in older patients evaluated using the multimorbidities group criteria included in the CIRS The aim of the present study was to establish a relationship between overprescribing of PPIs and multimorbidities in older patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None